Examkin

Question

Difficulty: HardGynecologic Infections

A 24-year-old nulligravid woman is evaluated in the hospital on the third day of admission for pelvic inflammatory disease complicated by a 4-cm left tubo-ovarian abscess. On admission, she presented with a temperature of 38.9°C (102.0°F), severe lower abdominal pain, and a leukocyte count of 18,500/mm³. She was started on intravenous cefoxitin and oral doxycycline. Today, she reports feeling much better. Her temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 78/min, and respirations are 14/min. Abdominal examination shows significantly decreased tenderness with no rebound or guarding. Pelvic examination reveals markedly improved cervical motion tenderness and a stable left adnexal fullness. She is tolerating a regular diet, and her leukocyte count has decreased to 9,200/mm³. Which of the following is the most appropriate next step in management?

  1. A
    Continue intravenous cefoxitin and oral doxycycline for a total of 14 days
  2. Switch to oral doxycycline and oral metronidazole to complete a 14-day courseAnswer
  3. C
    Switch to oral doxycycline monotherapy to complete a 14-day course
  4. D
    Perform computed tomography-guided percutaneous drainage of the abscess
  5. E
    Switch to oral amoxicillin-clavulanate to complete a 14-day course

Answer

Switch to oral doxycycline and oral metronidazole to complete a 14-day course
The correct step is to switch to oral doxycycline and oral metronidazole. Tubo-ovarian abscess (TOA) is a severe complication of pelvic inflammatory disease. The initial management for an unruptured TOA in a hemodynamically stable patient is hospitalization and parenteral broad-spectrum antibiotics (e.g., cefoxitin and doxycycline). If the patient demonstrates significant clinical improvement—such as resolution of fever, decreased abdominal pain, and down-trending leukocytosis—after 24 to 48 hours of parenteral therapy, they can be safely transitioned to an oral step-down regimen. Because a TOA involves a polymicrobial infection with a heavy burden of anaerobic bacteria, the oral regimen MUST include specific anaerobic coverage (such as metronidazole or clindamycin) in addition to doxycycline to complete a total 14-day course.

Step-by-Step Solution

1
Identify the patient's diagnosis and clinical trajectory.
The patient has pelvic inflammatory disease complicated by a 4-cm tubo-ovarian abscess and has shown significant clinical improvement after 48 hours of parenteral antibiotics.
Determining whether the patient is clinically stable or worsening dictates the need for surgical intervention versus continued medical management.
2
Determine the indication for surgical or percutaneous drainage of a tubo-ovarian abscess.
Drainage is generally reserved for abscesses that are ruptured, large (e.g., > 7-9 cm), or fail to improve after 48-72 hours of parenteral antibiotics.
Because this patient's abscess is 4 cm and she is rapidly improving, she does not require drainage and can continue with medical management.
3
Determine the appropriate antibiotic step-down therapy for a tubo-ovarian abscess.
Patients who improve on parenteral therapy can be transitioned to an oral regimen. The regimen must include coverage for both common sexually transmitted pathogens and anaerobes.
Tubo-ovarian abscesses have a significant anaerobic component. Therefore, the oral step-down regimen must include anaerobic coverage (e.g., metronidazole) in addition to doxycycline to complete a total 14-day course.

Key Concept

Patients with an unruptured tubo-ovarian abscess who demonstrate clinical improvement after 24-48 hours of parenteral antibiotics should be transitioned to an oral step-down regimen that includes robust anaerobic coverage, such as doxycycline and metronidazole, to complete a 14-day course.
Estimated Time:1m 30s
Rate this question

Topics

Gynecologic Infections

More questions from this topic